Found: 4
Select item for more details and to access through your institution.
Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 483, p. N.PAG, doi. 10.1126/scitranslmed.aau2086
- By:
- Publication type:
- Article
In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 8, p. 1, doi. 10.1371/journal.pntd.0007636
- By:
- Publication type:
- Article
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 2, p. 1, doi. 10.1371/journal.pntd.0007159
- By:
- Publication type:
- Article
'The next big thing' in diabetes: clinical progress on DPP-IV inhibitors.
- Published in:
- Drug Development Research, 2006, v. 67, n. 8, p. 627, doi. 10.1002/ddr.20138
- By:
- Publication type:
- Article